The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Next-generation characterization of the Cancer Cell Line Encyclopedia
Open accessAbstract
Large panels of comprehensively characterized human cancer models, including the Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to study genetic variants, candidate targets, and small-molecule and biological therapeutics and to identify new marker-driven cancer dependencies. To improve our understanding of the molecular features that contribute to cancer phenotypes, including drug responses, here we have expanded the characterizations of cancer cell lines to include genetic, RNA splicing, DNA methylation, histone H3 modification, microRNA expression and reverse-phase protein array data for 1,072 cell lines from individuals of various lineages and ethnicities. Integration of these data with functional characterizations such as drug-sensitivity, short hairpin RNA knockdown and CRISPR–Cas9 knockout data reveals potential targets for cancer drugs and associated biomarkers. Together, this dataset and an accompanying public data portal provide a resource for the acceleration of cancer research using model cancer cell lines. The original Cancer Cell Line Encyclopedia (CCLE) is expanded with deeper characterization of over 1,000 cell lines, including genomic, transcriptomic, and proteomic data, and integration with drug-sensitivity and gene-dependency data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Through systematic mining of databases for correlations between the cytotoxicity of 4,518 clinical and pre-clinical small molecules and E3 ligase expression levels across hundreds of human cancer cell lines,3–5 we identified CR8, a cyclin-dependent kinase (CDK) inhibitor,6 as a compound that acts as a molecular glue degrader.”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
(2008) · Journal of Machine Learning Research · Cited by 33,051
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Self-citationAnalysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,008
Identifying tumor cells at the single-cell level using machine learning
Dohmen, J., Baranovskii, A., Ronen, J., Uyar, B., Franke, V., & Akalin, A. (2022) · Genome biology · doi:10.1186/s13059-022-02683-1 · Cited by 63
“To test this hypothesis, we inspected the correlation of the tumor gene set scores with the growth rates detected in Patient Derived Xenograft (PDX) samples from [37] and the doubling times of the cancer cell lines from CCLE [38].”
MethodGustafsson, J., Anton, M., Roshanzamir, F., Jörnsten, R. J., Kerkhoven, E. J., Robinson, J. L., & Nielsen, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217868120 · Cited by 69
“We evaluated the performance of the previous and new version of tINIT using gene essentiality analysis on 891 cell lines from DepMap (17, 18), which showed a similar ability of the produced models to predict gene essentiality (Fig.”
MethodInfluentialZhu, M., Kim, J., Deng, Q., Ricciuti, B., Alessi, J. V., Eglenen-Polat, B., Bender, M. E., Huang, H.-C., Kowash, R., Cuevas, I., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.006 · Cited by 66
Self-citationSynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction
Guo, Y., Hu, H., Chen, W., Yin, H., Wu, J., Hsieh, C., He, Q., & Cao, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae015 · Cited by 68
“Besides, we chose the top 1000 genes with the highest variation in gene expression for cancer cell lines in the CCLE project [33, 34] and the top 1500 varied genes from tumor samples in TCGA [35].”
Güleç, Ö., Duran, H. E., Arslan, M., Yıldıztekin, G., Ece, A., & Türkeş, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108861 · Cited by 69
BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
Green, A. L., DeSisto, J. A., Flannery, P. C., Lemma, R., Knox, A. J., Lemieux, M. E., Sanford, B. L., O’Rourke, R., Ramkissoon, S. H., Jones, K. L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1125-7 · Cited by 69
Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression
Ito, J., Kimura, I., Soper, A., Coudray, A., Koyanagi, Y., Nakaoka, H., Inoue, I., Turelli, P., Trono, D., & Sato, K. (2020) · Science Advances · doi:10.1126/sciadv.abc3020 · Cited by 63
Neggers, J. E., Paolella, B. R., Asfaw, A., Rothberg, M. V., Skipper, T. A., Yang, A., Kalekar, R. L., Krill-Burger, J. M., Dharia, N. V., Kugener, G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108493 · Cited by 62
Self-citationLv, J., Liu, Y., Mo, S., Zhou, Y., Chen, F., Cheng, F., Li, C., Saimi, D., Liu, M., Zhang, H., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00857-4 · Cited by 65
Self-citationWang, T., Wang, R., & Wei, L. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00709 · Cited by 64
An integrated landscape of protein expression in human cancer
Jarnuczak, A. F., Najgebauer, H., Barzine, M., Kundu, D. J., Ghavidel, F. Z., Pérez‐Riverol, Y., Papatheodorou, I., Brāzma, A., & Vizcaíno, J. A. (2021) · Scientific Data · doi:10.1038/s41597-021-00890-2 · Cited by 65
Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
Hodis, E., Triglia, E. T., Kwon, J., Biancalani, T., Zakka, L. R., Parkar, S., Hütter, J.-C., Buffoni, L., Delorey, T. M., Phillips, D., et al. (2022) · Science · doi:10.1126/science.abi8175 · Cited by 61
Self-citationAssessment of modelling strategies for drug response prediction in cell lines and xenografts
Kurilov, R., Haibe‐Kains, B., & Brors, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-59656-2 · Cited by 62
Waddell, A. R., Mahmud, I., Ding, H., Huo, Z., & Liao, D. (2021) · Cancers · doi:10.3390/cancers13112799 · Cited by 62
Campeanu, I. J., Jiang, Y., Liu, L., Pilecki, M., Najor, A., Cobani, E., Manning, M., Zhang, X. M., & Yang, Z.-Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-94019-5 · Cited by 62
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Zhang, Y., Vu, T., Palmer, D. C., Kishton, R. J., Gong, L., Huang, J., Nguyen, T., Chen, Z., Smith, C., Livák, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01799-y · Cited by 64
Assigning functionality to cysteines by base editing of cancer dependency genes
Li, H., Ma, T., Remsberg, J. R., Won, S. J., DeMeester, K. E., Njomen, E., Ogasawara, D., Zhao, K. T., Huang, T. P., Lu, B., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01428-w · Cited by 62
“…output of modern large-scale sequencing and genetic screening efforts, which are identifying a broad array of human disease-relevant genes that code for protein types such as DNA/RNA-binding or adapter/scaffolding proteins 2,3 that have historically been challenging to target with small molecules.”
BackgroundSelf-citationTargeting lysine acetylation readers and writers
Zhou, M., & Cole, P. A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01080-6 · Cited by 68
“Truncation of TAZ2 leads to the activation of p300/ CBP KAT, explaining the gain-of-function mutations in p300/CBP that are associated with cancers 23,24 .”
A hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
Fernández-Torras, A., Duran-Frigola, M., Bertoni, M., Locatelli, M., & Aloy, P. (2022) · Nature Communications · doi:10.1038/s41467-022-33026-0 · Cited by 59
“We obtained similar results when we reversed the exercise and used CCLE embeddings to recapitulate GDSC similarities (Supplementary Fig.”
BackgroundMethodInfluentialBertucci, F., Boudin, L., Finetti, P., Berckelaer, C. V., van Dam, P. A., Dirix, L. Y., Viens, P., Gonçalvès, A., Ueno, N. T., Laere, S. V., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1929724 · Cited by 60
Durinikova, E., Buzo, K., & Arena, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01981-z · Cited by 61
Proteogenomic characterization of cholangiocarcinoma
Deng, M., Ran, P., Chen, L., Wang, Y., Yu, Z., Cai, K., Feng, J., Qin, Z., Yin, Y., Tan, S., et al. (2022) · Hepatology · doi:10.1002/hep.32624 · Cited by 61
“In support of this hypothesis, we evaluated the drug responses of human eCCA (EGI‐1) and iCCA (ETK‐1, HuCCT1) cells lines to eight VEGF/VEGFR inhibitors (Brivanib, Linifanib, BIBF‐1120, Ponatinib, Cediranib, Sorafenib, Foretinib, and Tivozanib) from the drug database,[26] and area under the curve of eCCA was significa…”
MethodIGSF8 is an innate immune checkpoint and cancer immunotherapy target
Li, Y., Wu, X., Sheng, C., Liu, H., Liu, H., Tang, Y., Liu, C., Ding, Q., Xie, B., Xiao, X., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.039 · Cited by 66
Singh, D. P., Kour, P., Banerjee, T., & Swain, D. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10255-2 · Cited by 61
An ultrasensitive method for detection of cell-free RNA
Nesselbush, M. C., Luca, B. A., Jeon, Y.-J., Jabara, I., Meador, C. B., Garofalo, A., Binkley, M. S., Hui, A. B., Erve, I. V. ’., Xu, N., et al. (2025) · Nature · doi:10.1038/s41586-025-08834-1 · Cited by 64
ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
Szczepanski, A. P., Zhao, Z., Sosnowski, T., Goo, Y. A., Bartom, E. T., & Wang, L. (2020) · Genome Medicine · doi:10.1186/s13073-020-00760-3 · Cited by 60
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastomaPreprint
Mitchell, K., Sprowls, S. A., Arora, S., Shakya, S., Silver, D. J., Goins, C. M., Wallace, L. C., Roversi, G. A., Schafer, R., Kay, K. E., et al. (2023) · Genes & Development · doi:10.1101/gad.349803.122 · Cited by 62
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
Ngan, H.-L., Liu, Y., Fong, A., Poon, P. H. Y., Yeung, C. K., Chan, S. S. M., Lau, A., Piao, W., Li, H., Tse, J. S. W., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.201900545 · Cited by 64
Self-citationZimmerman, S. M., Fropf, R., Kulasekara, B. R., Griswold, M., Appelbe, O. K., Bahrami, A. J., Boykin, R., Buhr, D. L., Fuhrman, K. A., Hoang, M. L., et al. (2022) · Genome Research · doi:10.1101/gr.276206.121 · Cited by 60
Shi, M., Meng, X., Fontugne, J., Chen, C.-L., Radvanyi, F., & Bernard‐Pierrot, I. (2020) · Genome Medicine · doi:10.1186/s13073-020-00781-y · Cited by 57
Germline Variants That Affect Tumor Progression
Chatrath, A., Ratan, A., & Dutta, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.10.005 · Cited by 57
Somerville, T. D. D., Xu, Y., Wu, X., Maia-Silva, D., Hur, S. K., de Almeida, L. M. N., Preall, J. B., Koo, P. K., & Vakoc, C. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921484117 · Cited by 60
Discovering and validating cancer genetic dependencies: approaches and pitfalls
Lin, A., & Sheltzer, J. M. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0247-7 · Cited by 59
T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
Canel, M., Taggart, D., Sims, A. H., Lonergan, D. W., Waizenegger, I. C., & Serrels, A. (2020) · eLife · doi:10.7554/elife.48092 · Cited by 62
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Iyyanki, T., Zhang, B., Wang, Q., Hou, Y., Jin, Q., Xu, J., Yang, H., Liu, T., Wang, X., Song, F., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02325-y · Cited by 59
Sakamoto, Y., Zaha, S., Nagasawa, S., Miyake, S., Kojima, Y., Suzuki, A., Suzuki, Y., & Seki, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab397 · Cited by 58
A landscape of response to drug combinations in non-small cell lung cancer
Nair, N. U., Greninger, P., Zhang, X., Friedman, A. A., Amzallag, A., Cortez, E., Sahu, A. D., Lee, J. S., Dastur, A., Egan, R. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39528-9 · Cited by 63
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Chen, M., Bie, L., & Ying, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115514 · Cited by 60
Intrinsic electrical activity drives small-cell lung cancer progression
Peinado, P., Stazi, M., Ballabio, C., Margineanu, M.-B., Li, Z., Colón, C. I., Hsieh, M., Choudhuri, S. P., Stastny, V., Hamilton, S., et al. (2025) · Nature · doi:10.1038/s41586-024-08575-7 · Cited by 67
Tomihara, H., Carbone, F., Perelli, L., Huang, J. K.-L., Soeung, M., Rose, J. L., Robinson, F. S., Lissanu, Y., Feng, N., Takeda, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3922 · Cited by 57
Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants
Mehmood, A., Kaushik, A. C., Wang, Q., Li, C.-D., & Wei, D. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00488 · Cited by 57
The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters
Rosenberger, F. A., Moore, D., Atanassov, I., Moedas, M. F., Clemente, P., Végvári, Á., Fissi, N. E., Filograna, R., Bucher, A.-L., Hinze, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf0717 · Cited by 58
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation
Khadka, P., Reitman, Z. J., Lu, S. D., Buchan, G. B. J., Gionet, G. L., Dubois, F. P. B., Carvalho, D. M., Shih, J., Zhang, S., Greenwald, N. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28198-8 · Cited by 58
“We examined whether PPM1D dependency was linked to genetic activation of PPM1D using pooled CRISPR-cas9 assays across 558 cancer cell lines 17,18 .”
InfluentialSelf-citationHiga, K. C., Goodspeed, A., Chavez, J. S., De Dominici, M., Danis, E., Zaberezhnyy, V., Rabe, J. L., Tenen, D. G., Pietras, E. M., & DeGregori, J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200560 · Cited by 57
Cotto, K. C., Feng, Y.-Y., Ramu, A., Richters, M. M., Freshour, S. L., Skidmore, Z. L., Xia, H., McMichael, J. F., Kunisaki, J., Campbell, K. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/436634 · Cited by 59
Georgopoulou, D., Callari, M., Rueda, O. M., Shea, A., Martin, A. G., Giovannetti, A., Qosaj, F., Dariush, A. A., Chin, S., Carnevalli, L. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22303-z · Cited by 54
Self-citationMYC regulates a pan-cancer network of co-expressed oncogenic splicing factors
Urbanski, L. M., Brugiolo, M., Park, S., Angarola, B. L., Leclair, N. K., Yurieva, M., Palmer, P., Sahu, S. K., & Anczuków, O. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111704 · Cited by 53
Zhang, X., Zhuge, J., Liu, J., Xia, Z., Wang, H., Gao, Q., Jiang, H., Qu, Y., Fan, L., Ma, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1153423 · Cited by 56
“We obtained the mRNA expression matrix for tumor cell lines from the CCLE dataset (33).”
MethodMayoh, C., Mao, J., Xie, J., Tax, G., Chow, S., Cadiz, R., Pazaky, K., Barahona, P., Ajuyah, P., Trebilcock, P., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3702 · Cited by 56
“A one-sided Wilcoxon test was performed to statistically compare the AUC (31) difference between MYCN amplified (N 1⁄4 6) versus MYCN wild-type (N 1⁄4 14) classical neuroblastoma cell lines.”
ExonSkipDB: functional annotation of exon skipping event in human
Kim, P., Yang, M., Yiya, K., Zhao, W., & Zhou, X. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz917 · Cited by 58
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
Hynds, R. E., Frese, K. K., Pearce, D. R., Gronroos, E. C., Dive, C., & Swanton, C. (2021) · Open Biology · doi:10.1098/rsob.200247 · Cited by 59
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1
Sflomos, G., Battista, L., Aouad, P., Martino, F. D., Scabia, V., Stravodimou, A., Ayyanan, A., Ifticene‐Treboux, A., RLS, Bücher, P., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013180 · Cited by 57
Liang, S., Hsu, C.-C., Song, H., Huang, Y.-C., Kuo, C.-W., Yao, X., Li, C., Yang, H.-C., Hung, Y.-L., Chao, S.-Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01895-2 · Cited by 54
Marinello, J., Arleo, A., Russo, M. V., Delcuratolo, M., Ciccarelli, F. D., Pommier, Y. G., & Capranico, G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01894-4 · Cited by 56
“Furthermore, through a survey of Cancer Cell Line Encyclopaedia (CCLE) data [41], we observed that small-cell lung cancer cell lines DMS114, H889, and, to a lower extent, H209, show a high methylation level of STING gene that strongly affects gene expression, that is lower than STING expression in HeLa cells (Suppleme…”
BackgroundThe Network Zoo: a multilingual package for the inference and analysis of gene regulatory networks
Guebila, M. B., Wang, T., Lopes‐Ramos, C. M., Fanfani, V., Weighill, D., Burkholz, R., Schlauch, D., Paulson, J. N., Altenbuchinger, M., Shutta, K. H., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02877-1 · Cited by 55
“Global chromatin profiling data was assessed for 42 modified and unmodified H3 tail peptides across 897 cells and measured their abundances [36].”
MethodChromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns
Watson, E. V., Lee, J. J.-K., Gulhan, D., Melloni, G. E. M., Venev, S. V., Magesh, R. Y., Frederick, A., Chiba, K., Wooten, E. C., Naxerova, K., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01665-2 · Cited by 53
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
Weller, C. E., Burnett, G. L., Jiang, L., Chakraborty, S., Zhang, D., Vita, N. A., Dilly, J., Kim, E., Maldonato, B. J., Seamon, K. J., et al. (2025) · Science · doi:10.1126/science.ads0239 · Cited by 64
Self-citationPan, J., Silva, T. C., Gull, N., Yang, Q., Plummer, J., Chen, S., Daigo, K., Hamakubo, T., Gery, S., Ding, L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0390 · Cited by 54
Yi, H., Li, G., Long, Y., Liang, W., Cui, H., Zhang, B., Tan, Y., Li, Y., Shen, L., Deng, D., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1351-z · Cited by 55
Leveraging Single-Cell Approaches in Cancer Precision Medicine
Nath, A., & Bild, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.007 · Cited by 57
Epigenetic state determines inflammatory sensing in neuroblastoma
Wolpaw, A. J., Grossmann, L. D., Dessau, J. L., Dong, M. M., Aaron, B., Brafford, P. A., Volgina, D., Pascual‐Pasto, G., Rodríguez-García, A., Uzun, Y., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102358119 · Cited by 53
Li, Z., Zhang, H., Li, Q., Feng, W., Jia, X., Zhou, R., Huang, Y., Li, Y., Hu, Z., Hu, X., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02257-1 · Cited by 55
Laine, A., Nagelli, S. G., Farrington, C., Butt, U., Cvrljevic, A. N., Vainonen, J. P., Feringa, F. M., Grönroos, T. J., Gautam, P., Khan, S., et al. (2020) · doi:10.1101/2020.08.27.269902 · Cited by 54
Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells
Kong, H., Kwon, E., Kwon, O., Lee, H., Choi, J., Kim, Y., Kim, W., & Cha, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5153 · Cited by 54
Leo, I. R., Aswad, L., Stahl, M. M. S., Kunold, E., Post, F., Erkers, T., Struyf, N., Mermelekas, G., Joshi, R. N., Villacampa, E. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29224-5 · Cited by 57
“For the REH cell line, which harbors a GINS2 mutation (P19S) 35 , protein-mRNA differences for GINS-complex members were signi fi cantly larger than differences for corresponding protein-mRNA pairs in other cell lines (average standardized residuals = − 5.08, Supplementary Data 9).”
InfluentialAP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells
Comandante-Lou, N., Baumann, D. G., & Fallahi‐Sichani, M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111147 · Cited by 55
Hyeon, D. Y., Nam, D., Han, Y., Kim, D. K., Kim, G., Kim, D., Bae, J., Back, S., Mun, D., Madar, I. H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00479-7 · Cited by 57
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
Zhou, J., Tang, D., He, L., Lin, S., Lei, J. H., Sun, H., Xu, X., & Deng, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106830 · Cited by 54
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies
Liu, Z., Liu, Y., Qian, L., Jiang, S., Gai, X., Ye, S., Chen, Y., Wang, X., Zhai, L., Xu, J. Q., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.021 · Cited by 55
Ayoubi, R., Ryan, J., Biddle, M. S., Alshafie, W., Fotouhi, M., Bolivar, S. G., Ruiz Moleon, V., Eckmann, P., Worrall, D., McDowell, I., et al. (2023) · eLife · doi:10.7554/elife.91645.2 · Cited by 53
Endogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 56
A framework for fibrolamellar carcinoma research and clinical trials
Dinh, T. A., Utria, A. F., Barry, K. C., Ma, R. K., Abou‐Alfa, G. K., Gordan, J. D., Jaffee, E. M., Scott, J. D., Zucman‐Rossi, J., O'Neill, A. F., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00580-3 · Cited by 54
Luo, X., Archibeque, I., Dellamaggiore, K., Smither, K., Homann, O. R., Lipford, J. R., & Mohl, D. A. (2022) · iScience · doi:10.1016/j.isci.2022.103985 · Cited by 55
Noble, R. A., Thomas, H. D., Zhao, Y., Herendi, L., Howarth, R., Dragoni, I., Keun, H. C., Vellano, C. P., Marszalek, J. R., & Wedge, S. R. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01848-w · Cited by 53
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Chong, W., Zhu, X., Ren, H., Ye, C., Xu, K., Wang, Z., Jia, S., Shang, L., Li, L., & Chen, H. (2022) · Theranostics · doi:10.7150/thno.73089 · Cited by 56
A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements
Martin, S., Scorzoni, S., Cordone, S., Mazzagatti, A., Beznoussenko, G. V., Gunn, A., Bona, M. D., Eliezer, Y., Leor, G., Ben-Yishay, T., et al. (2024) · Science · doi:10.1126/science.adj7446 · Cited by 56
Neckmann, U., Wolowczyk, C., Hall, M., Almaas, E., Ren, J., Zhao, S., Johannessen, B., Skotheim, R. I., Bjørkøy, G., ten Dijke, P., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0467-7 · Cited by 55
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
Becker, J. P., Helm, D., Rettel, M., Stein, F., Hernandez‐Sanchez, A., Urban, K., Gebert, J. F., Kloor, M., Neu‐Yilik, G., Doeberitz, M. V. K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102389 · Cited by 50
Colangelo, T., Carbone, A., Mazzarelli, F., Cuttano, R., Dama, E., Nittoli, T., Albanesi, J., Barisciano, G., Forte, N. R., Palumbo, O., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00935-y · Cited by 52
“To tackle this issue, we started by analyzing the TIM expression profile in a panel of 63 CRC cell lines belonging to the cancer cell line encyclopedia (Table S1) [20].”
MethodMirhadi, S., Tam, S., Li, Q., Moghal, N., Pham, N., Tong, J., Golbourn, B. J., Krieger, J. R., Taylor, P. P., Li, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29444-9 · Cited by 50
Replication Stress Defines Distinct Molecular Subtypes Across Cancers
Takahashi, N., Kim, S. H., Schultz, C. W., Rajapakse, V. N., Zhang, Y., Redon, C. E., Fu, H., Pongor, L. S., Kumar, S., Pommier, Y. G., et al. (2021) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0168 · Cited by 64
Zhang, D., Lü, W., Cui, S., Mei, H., Wu, X., & Zhuo, Z. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01059-0 · Cited by 56
Human SMARCA5 is continuously required to maintain nucleosome spacing
Bomber, M. L., Wang, J., Liu, Q., Barnett, K. R., Layden, H. M., Hodges, E. C., Stengel, K. R., & Hiebert, S. W. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.018 · Cited by 58
Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis
Gitego, N., Agianian, B., Mak, O. W., Vasantha Kumar, M. V., Cheng, E. H. Y., & Gavathiotis, E. (2023) · Nature Communications · doi:10.1038/s41467-023-44084-3 · Cited by 53
“45 .”
BackgroundHoti, D., Nixha, A. R., Duran, H. E., Arslan, M., Yıldıztekin, G., Ece, A., & Türkeş, C. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118416 · Cited by 52
Hu, M., Fu, X., Si, Z., Li, C., Sun, J., Du, X., & Zhang, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01245 · Cited by 52
Tinhofer, I., Braunholz, D., & Klinghammer, K. F. (2020) · Cancers of the Head & Neck · doi:10.1186/s41199-020-00056-4 · Cited by 55
Fernández, L. P., Merino, M. J., Colmenarejo, G., Moreno‐Rubio, J., Sánchez‐Martínez, R., Quijada‐Freire, A., de Cedrón, M. G., Reglero, G., Casado, E., Sereno, M., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12816 · Cited by 51
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment
Sponagel, J., Jones, J. K., Frankfater, C., Zhang, S., Tung, O., Cho, K., Tinkum, K. L., Gass, H., Núñez, E., Spitz, D. R., et al. (2022) · Med · doi:10.1016/j.medj.2022.08.005 · Cited by 51
Mall, R., Bynigeri, R. R., Karki, R., Malireddi, R. K. S., Sharma, B. R., & Kanneganti, T. (2022) · NAR Cancer · doi:10.1093/narcan/zcac033 · Cited by 55
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
Bu, J., Zhang, Y., Wu, S., Li, H., Sun, L., Liu, Y., Zhu, X., Qiao, X., Ma, Q., Liu, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38097-1 · Cited by 51
“The mRNA expression data of KK-LC-1 in various breast cancer cell lines were obtained from CancerCellLine Encyclopedia (CCLE)(https://sites.broadinstitute.org/ ccle/tools) 22 .”
Self-citationIRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing
Pan, Y., Phillips, J. W., Zhang, B. D., Noguchi, M., Kutschera, E., McLaughlin, J., Nesterenko, P. A., Mao, Z., Bangayan, N. J., Wang, R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221116120 · Cited by 50
RAD51 protects abasic sites to prevent replication fork breakage
Hanthi, Y. W., Ramírez-Otero, M. A., Appleby, R. E., Antoni, A. D., Joudeh, L. I., Sannino, V., Waked, S., Ardizzoia, A., Barra, V., Fachinetti, D., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.07.004 · Cited by 50
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Zerbib, J., Ippolito, M. R., Eliezer, Y., Feudis, G. D., Reuveni, E., Kadmon, A. S., Martin, S., Viganò, S., Leor, G., Berstler, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52176-x · Cited by 49
“We then examined whether MEK and ERK activities are also associated with aneuploidy in human cancer cells, and found an increased activity of both MEK and ERK in highly-aneuploid cancer cells 62 (Fig.”
Influentialm6A alters ribosome dynamics to initiate mRNA degradation
Murakami, S., Olarerin-George, A. O., Liu, J. F., Zaccara, S., Hawley, B. R., & Jaffrey, S. R. (2025) · Cell · doi:10.1016/j.cell.2025.04.020 · Cited by 56
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Gong, L., Luo, J., Yang, E., Ru, B., Qi, Z., Yang, Y., Rani, A., Purohit, A., Zhang, Y., Guan, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.004 · Cited by 56
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells
Chen, F., Ding, K., Priedigkeit, N., Elangovan, A., Levine, K. M., Carleton, N. M., Savariau, L., Atkinson, J. M., Oesterreich, S., & Lee, A. V. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0696 · Cited by 49
Identification of a quality-control factor that monitors failures during proteasome assembly
Zavodszky, E., Peak-Chew, S.-Y., Juszkiewicz, S., Narvaez, A. J., & Hegde, R. S. (2021) · Science · doi:10.1126/science.abc6500 · Cited by 45
Bradbury, A., O'Donnell, R. L., Drew, Y., Curtin, N. J., & Saha, S. S. (2020) · Cancers · doi:10.3390/cancers12071939 · Cited by 52
Metadata
- Authors
- Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., Hu, K., Andreev-Drakhlin, A. Y., Kim, J., Hess, J. M., Haas, B. J., Aguet, F., Weir, B. A., Rothberg, M. V., Paolella, B. R., Lawrence, M. S., Akbani, R., Lu, Y., Tiv, H. L., Gokhale, P. C., de Weck, A., Mansour, A. A., Oh, C., Shih, J., Hadi, K., Rosen, Y., Bistline, J., Venkatesan, K., Reddy, A., Sonkin, D., Liu, M., Lehar, J., Korn, J. M., Porter, D. A., Jones, M. D., Golji, J., Caponigro, G., Taylor, J. E., Dunning, C. M., Creech, A. L., Warren, A. C., McFarland, J. M., Zamanighomi, M., Kauffmann, A., Stransky, N., Imielinski, M., Maruvka, Y. E., Cherniack, A. D., Tsherniak, A., Vazquez, F., Jaffe, J. D., Lane, A. A., Weinstock, D. M., Johannessen, C. M., Morrissey, M. P., Stegmeier, F., Schlegel, R., Hahn, W. C., Getz, G., Mills, G. B., Boehm, J. S., Golub, T. R., Garraway, L. A., & Sellers, W. R.
- Affiliations
- Broad Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Cornell University (US)
- National Cancer Institute (US)
- Novartis Institutes for BioMedical Research (CH)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Sellers, William R.
- ORCID
- Ghandi, Mahmoud
- Huang, Franklin W.
- Kryukov, Gregory V.
- McDonald, E. Robert
- Barretina, Jordi
- Li, Haoxin
- Hu, Kevin
- Andreev-Drakhlin, Alexander Y.
- Kim, Jaegil
- Hess, Julian M.
- Haas, Brian J.
- Aguet, François
- Rothberg, Michael V.
- Paolella, Brenton R.
- Lawrence, Michael S.
- Akbani, Rehan
- Lu, Yiling
- Tiv, Hong L.
- Gokhale, Prafulla C.
- Oh, Coyin
- Shih, Juliann
- Hadi, Kevin
- Rosen, Yanay
- Venkatesan, Kavitha
- Reddy, Anupama
- Sonkin, Dmitriy
- Liu, Manway
- Korn, Joshua M.
- Jones, Michael D.
- Taylor, Jordan E.
- Creech, Amanda L.
- McFarland, James M.
- Zamanighomi, Mahdi
- Kauffmann, Audrey
- Stransky, Nicolas
- Imielinski, Marcin
- Maruvka, Yosef E.
- Cherniack, Andrew D.
- Tsherniak, Aviad
- Jaffe, Jacob D.
- Lane, Andrew A.
- Weinstock, David M.
- Johannessen, Cory M.
- Stegmeier, Frank
- Hahn, William C.
- Getz, Gad
- Mills, Gordon B.
- Boehm, Jesse S.
- Golub, Todd R.
- Garraway, Levi A.
- Sellers, William R.
- Venue
- Nature
- Published
- 2019-05
- Volume
- 569
- Issue
- 7757
- Pages
- 503-508
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6697103
- OpenAlex
- W2944727022
- Semantic Scholar
- b3631d8d2656c0c72ad92f3b0a77af2afde649a5
- Cited by
- 3,394
- References
- 67
- Citations by year
- 2026: 297 · 2025: 472 · 2024: 560 · 2023: 551 · 2022: 550 · 2021: 594 · 2020: 306 · 2019: 59
- FWCI
- 121.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- European Hematology Association (TRTH56)
- National Institutes of Health (5r21da025720-02)
- National Institute on Drug Abuse (R21-DA025720)
- National Cancer Institute (R50CA221675, P50CA217685, R01CA219943, P50CA098258, U24CA180922, U54CA224068, U24CA210949, U24CA210950, R50CA211461, R37CA225191, U01CA217842, U01CA176058, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Cancer Cell Line Encyclopedia, cancer cell lines, drug sensitivity, gene dependency, RNA splicing, DNA methylation, histone H3 modifications, microRNA expression, reverse phase protein array, CRISPR/Cas9 knockout, shRNA knockdown, therapeutic target, biomarkers, multi-omics integration, public data portals
- MeSH terms
- Gene Editing, Antineoplastic Agents, Ethnicity, Histones, Humans, Neoplasms, RNA Splicing, Biomarkers, Tumor, Drug Resistance, Neoplasm, DNA Methylation, MicroRNAs, Protein Array Analysis, Cell Line, Tumor, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
